Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized trial of Ginkgolide Dripping Pills in acute ischemic stroke
CTR20220531Phase 3Completed
- Sponsor
- Hefei Innovation Pharmaceutical Technology
- Start
- Mar 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ginkgolide dripping pills in ischemic stroke, sponsored by Hefei Innovation Pharmaceutical Technology. Started Mar 2022; status: completed.
02
Drugs
ginkgolide dripping pills
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20220531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220531.